Utah Medical Products, Inc. (UTMD)

Utah Medical Products Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	40.9	50.22	52.28	49.05	42.18
Revenue Growth (YoY)	-18.56%	-3.94%	6.58%	16.30%	-10.08%
Cost of Revenue	16.76	20.19	20.09	18.14	16.63
Gross Profit	24.14	30.04	32.2	30.92	25.55
Selling, General & Admin	7.6	11.04	11.91	11.51	11.35
Research & Development	0.81	0.56	0.49	0.53	0.49
Operating Expenses	8.41	11.6	12.41	12.04	11.84
Operating Income	15.73	18.44	19.79	18.88	13.71
Interest & Investment Income	3.37	3.04	0.66	0.17	0.11
Currency Exchange Gain (Loss)	0	-0.01	-	-	-
Other Non Operating Income (Expenses)	-0.16	0.28	0.21	0.02	0.02
EBT Excluding Unusual Items	18.94	21.75	20.66	19.06	13.84
Legal Settlements	-2.14	-1.66	-	-	-
Pretax Income	16.8	20.09	20.66	19.06	13.84
Income Tax Expense	2.93	3.45	4.19	4.27	3.04
Net Income	13.87	16.64	16.47	14.79	10.8
Net Income to Common	13.87	16.64	16.47	14.79	10.8
Net Income Growth	-16.60%	0.98%	11.39%	36.95%	-26.68%
Shares Outstanding (Basic)	4	4	4	4	4
Shares Outstanding (Diluted)	4	4	4	4	4
Shares Change (YoY)	-3.68%	-0.16%	-0.46%	-0.33%	-1.79%
EPS (Basic)	3.96	4.58	4.53	4.05	2.95
EPS (Diluted)	3.96	4.57	4.52	4.04	2.94
EPS Growth	-13.42%	1.20%	11.88%	37.41%	-25.36%
Free Cash Flow	14.6	21.64	20.34	20.65	19.28
Free Cash Flow Per Share	4.17	5.95	5.58	5.64	5.25
Dividend Per Share	1.205	1.185	1.165	0.855	1.120
Dividend Growth	1.69%	1.72%	36.26%	-23.66%	1.82%
Gross Margin	59.03%	59.81%	61.58%	63.03%	60.57%
Operating Margin	38.46%	36.71%	37.85%	38.49%	32.50%
Profit Margin	33.92%	33.12%	31.51%	30.15%	25.60%
Free Cash Flow Margin	35.70%	43.09%	38.90%	42.10%	45.70%
EBITDA	18.53	24.75	26.82	26.16	20.88
EBITDA Margin	45.30%	49.28%	51.30%	53.33%	49.50%
D&A For EBITDA	2.8	6.32	7.03	7.28	7.17
EBIT	15.73	18.44	19.79	18.88	13.71
EBIT Margin	38.46%	36.71%	37.85%	38.49%	32.50%
Effective Tax Rate	17.43%	17.19%	20.26%	22.42%	21.98%

Updated Jan 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q